Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Jul 19, 2020
Open Peer Review Period: Jul 18, 2020 - Jul 28, 2020
Date Accepted: Oct 26, 2020
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Screening for Depression in Daily Life: Development and External Validation of a Prediction Model Based on Actigraphy and Experience Sampling Method

Minaeva O, Riese H, Lamers F, Antypa N, Wichers M, Booij SH

Screening for Depression in Daily Life: Development and External Validation of a Prediction Model Based on Actigraphy and Experience Sampling Method

J Med Internet Res 2020;22(12):e22634

DOI: 10.2196/22634

PMID: 33258783

PMCID: 7894744

Screening for depression in daily life: Development and external validation of a prediction model based on actigraphy and experience sampling of depressive affect and behaviors

  • Olga Minaeva; 
  • HarriĆ«tte Riese; 
  • Femke Lamers; 
  • Niki Antypa; 
  • Marieke Wichers; 
  • Sanne H Booij

ABSTRACT

Background:

In many countries, depressed individuals often first visit primary care settings for consultation, but a considerable number of clinically depressed patients remains unidentified. Introducing additional screening tools may facilitate the diagnostic process. We aimed to examine whether Experience Sampling Method (ESM)-based measures of depressive affect and behaviors can discriminate depressed from non-depressed individuals. In addition, the added value of actigraphy-based measures was examined.

Objective:

The aim of our study was to examine whether ESM-assessed depression-related affect and behavior can discriminate between depressed and non-depressed individuals, whether actigraphy data can discriminate between depressed and non-depressed individuals on its own, and whether it has added value with respect to the use of ESM.

Methods:

We used data from two samples to develop and validate prediction models. The development dataset included 14 days of ESM and continuous actigraphy of currently depressed (n=43) and non-depressed individuals (n=82). The validation dataset included 30 days of ESM and continuous actigraphy of currently depressed (n=27) and non-depressed individuals (n=27). Backward stepwise logistic regression analyses were applied to build the prediction models. Performance of the models was assessed with goodness of fit indices, calibration curves, and discriminative ability (AUC - the area under the receiver operating characteristic curve).

Results:

In the development dataset, the discriminative ability was good for the actigraphy model (AUC=.790) and excellent for the ESM (AUC=.991) and combined-domains model (AUC=.993). In the validation dataset, the discriminative ability was reasonable for the actigraphy model (AUC=.648) and excellent for the ESM (AUC=.891) and combined-domains model (AUC=.892).

Conclusions:

ESM was a good diagnostic predictor and is easy to calculate, and it therefore holds promise for implementation in clinical practice. Actigraphy showed no added value to ESM as a diagnostic predictor, but might still be useful when ESM use is restricted.


 Citation

Please cite as:

Minaeva O, Riese H, Lamers F, Antypa N, Wichers M, Booij SH

Screening for Depression in Daily Life: Development and External Validation of a Prediction Model Based on Actigraphy and Experience Sampling Method

J Med Internet Res 2020;22(12):e22634

DOI: 10.2196/22634

PMID: 33258783

PMCID: 7894744

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.